Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Somatostatin | Somatostatin is an endogenous peptide that inhibits the release of growth hormone, insulin and glucagon. Somatostatin also blocks voltage-dependent calcium channels. Uses: Hormones. Group: Pharmaceutical. Alternative Names: Somatostatin 14; Somatostatin-14; Panhibin; Somiaton. CAS No. 51110-01-1. Pack Sizes: 5 mg. Product ID: BAT-006115. Molecular formula: C76H104N18O19S2. Mole weight: 1637.88. Custom synthesis is available. Send your inquiries for more information. |  London |
| Acetyl-Lys5-octreotide Acetate | Acetyl-Lys5-octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: Lys(Ac)-Octreotide Acetate; D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl(acetyl)-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7). Pack Sizes: 10 mg. Product ID: B1370-458987. Molecular formula: C51H68N10O11S2.xC2H4O2. Mole weight: 1061.28 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| Acetyl-Phe1-octreotide Acetate | Acetyl-Phe1-octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanylD-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-, acetate (salt) (9CI); Ac-D-phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-Phe-Octreotide Acetate. CAS No. 83795-62-4. Pack Sizes: 10 mg. Product ID: B1370-458988. Molecular formula: C51H68N10O11S2.xC2H4O2. Mole weight: 1061.28 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| Ac-Octreotide | Ac-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: Ac-DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol(Cys2&Cys7 bridge); N2.1-Acetyloctreotide; Ac-D-Phe-c(Cys-Phe-D-Trp-Lys-Thr-Cys)-Thr-ol; Octreotide EP Impurity I; Ac-D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); N-Acetyl-Phe-Octreotide; L-Cysteinamide, N-acetyl-D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl. CAS No. 83795-61-3. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014620. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. Custom synthesis is available. Send your inquiries for more information. | London |
| BIM 23056 acetate | BIM 23056 acetate is a potent and surmountable human recombinant somatostatin receptor antagonist (Ki = 142, >1000, 10.8, 16.6 and 5.7 nM for human cloned sst1-5 receptors, respectively). It acts as an antagonist on SRIF14-induced [35S]-GTPγS binding at sst3 and sst5 receptors (PKB = 6.33 and 5.84, respectively). Group: Pharmaceutical. Alternative Names: H-D-Phe-Phe-Tyr-D-Trp-Lys-Val-Phe-D-2Nal-NH2.CH3CO2H; D-phenylalanyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-phenylalanyl-3-(2-naphthyl)-D-alaninamide acetic acid. CAS No. 2763584-06-9. Pack Sizes: 5 mg. Product ID: BAT-016403. Molecular formula: C73H85N11O11. Mole weight: 1292.52. Custom synthesis is available. Send your inquiries for more information. | London |
| CYN 154806 | CYN 154806 has been found to be a somatostatin sst2 receptor antagonist. Group: Pharmaceutical. Alternative Names: CYN 154806; CYN154806; CYN-154806. CAS No. 183658-72-2. Pack Sizes: 5 mg. Product ID: BAT-006162. Molecular formula: C56H68N12O14S2. Mole weight: 1197.35. Custom synthesis is available. Send your inquiries for more information. | London |
| (Cys(S)²)-Octreotide trifluoroacetate salt | Trisulfide Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: H-D-Phe-Cys(S)-Phe-D-Trp-Lys-Thr-Cys-L-threoninol trifluoroacetate salt (Trisulfide bond); Trisulfide Octreotide trifluoroacetate salt. Pack Sizes: 10 mg. Product ID: B1370-449815. Custom synthesis is available. Send your inquiries for more information. | London |
| D-allo-Thr(6)-Octreotide | D-allo-Thr(6)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys-DaThr-Cys-Thr-ol(Cys2&Cys7 bridge); [6-D-allothreonine]octreotide; DPhe-CF-DTrp-K-DaThr-C-Thr-ol(Cys2&Cys7 bridge); Octreotide EP Impurity A; (D-Phe)-Cys-Phe-(D-Trp)-Lys-(Dallo-Thr)-Cys-Thr-Ol (Disulfide bond Cys2/Cys7); D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-allo-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); D-Phe-Cys-Phe-D-Trp-Lys-D-allo-Thr-Cys-Thr-ol (Disulfide Bridge between Cys2-Cys7); Octreotide impurity A; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-allo-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide. CAS No. 1546983-12-3. Pack Sizes: 1mg;1g;10g. Product ID: BAT-017067. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. Custom synthesis is available. Send your inquiries for more information. | London |
| D-allo-Thr(6)-Octreotide trifluoroacetate salt | D-allo-Thr(6)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: B1370-449814. Custom synthesis is available. Send your inquiries for more information. | London |
| D-Cys(2)-Octreotide trifluoroacetate salt | D-Cys(2)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: H-D-Phe-D-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol trifluoroacetate salt (Disulfide bridge: Cys2-Cys7); Octreotide EP Impurity G trifluoroacetate salt. Pack Sizes: 10 mg. Product ID: B1370-449817. Custom synthesis is available. Send your inquiries for more information. | London |
| D-Cys(7)-Octreotide | D-Cys(7)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys-Thr-DCys-Thr-ol(Cys2&Cys7 bridge); [7-D-cysteine]octreotide; Octreotide EP Impurity B; [D-Cys7]-Octreotide; D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-D-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-D-Cys-Thr-ol (Disulfide bridge: Cys2-Cys7); D-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; DPhe-CF-DTrp-KT-DCys-Thr-ol(Cys2&Cys7 bridge). CAS No. 1211530-36-7. Pack Sizes: 10 mg. Product ID: B1370-425645. Molecular formula: C49H66N10O10S2. Mole weight: 1019.25. Custom synthesis is available. Send your inquiries for more information. | London |
| (Des-L-threoninol8)-Octreotide amide | (Des-L-threoninol8)-Octreotide amide is a potential impurity of octreotide. Octreotide is a synthetic somatostatin analog used to treat conditions involving excessive hormone production. It is administered via subcutaneous or intravenous injection and is effective in managing acromegaly, carcinoid syndrome, and Zollinger-Ellison syndrome. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-NH2(Cys2&Cys7 bridge); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-NH2 (Disulfide bridge: Cys2-Cys7); D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinamide cyclic (2-7)-disulfide; DPhe-CF-DTrp-KTC-NH2(Cys2&Cys7 bridge); (Des-Thr-ol8)-Octreotide amide; [Des-Thr-ol8]-Cys7-amide-Octreotide; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-, cyclic (2→7)-disulfide. CAS No. 79486-60-5. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014747. Molecular formula: C45H58N10O8S2. Mole weight: 931.13. Custom synthesis is available. Send your inquiries for more information. | London |
| Des-Threoninol-Octreotide | Des-Threoninol-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys-Thr-Cys(Cys2&Cys7 bridge); [Des-Thr-ol] Octreotide; Des-Thr-ol Octreotide; [Des-Thr-ol8] Octreotide; DPhe-CF-DTrp-KTC(Cys2&Cys7 bridge); D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystine (Disulfide Bridge between Cys2-Cys7); Octreotide impurity-11; H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-OH (Disulfide bridge: Cys2-Cys7); L-Cysteine, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-, cyclic (2→7)-disulfide; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteine cyclic (2→7)-disulfide. CAS No. 160841-00-9. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014382. Molecular formula: C45H57N9O9S2. Mole weight: 932.13. Custom synthesis is available. Send your inquiries for more information. | London |
| DOTA-NOC | DOTA-NOC is a potent chelating agent extensively used in radiopharmaceuticals for the targeted imaging and therapy of neuroendocrine tumors. By combining with diverse radiometals, such as lutetium-177 or yttrium-90, it generates therapeutic agents that specifically bind to neuroendocrine tumor cells. The DOTA-NOC derivatives have displayed remarkable specificity and affinity for somatostatin receptors, endowing it with a unique potential for cancer therapy. Its diverse applications stem from its impressive properties, which include high burstiness in sentence structure and an elevated level of perplexity in its descriptions. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; DOTA-[Nal3]-octreotide; H-D-Phe(DOTA)-Cys(1)-Nal-D-Trp-Lys-Thr-Cys(1)-Thr-ol; DOTA-D-Phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)-L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol (2->7)-disulfide. CAS No. 619300-53-7. Pack Sizes: 1 mg. Product ID: B2699-192721. Molecular formula: C69H94N14O17S2. Mole weight: 1455.7. Custom synthesis is available. Send your inquiries for more information. | London |
| DOTATATE acetate | DOTATATE acetate is a radiolabeled somatostatin analog used in medical imaging and therapy for neuroendocrine tumors (NETs). DOTATATE acetate is a peptide derivative that binds selectively to somatostatin receptors (mainly subtype 2), which are overexpressed on the surface of neuroendocrine tumor cells. This allows for specific targeting of these tumors. Group: Pharmaceutical. Alternative Names: L-Threonine, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-, cyclic (2→7)-disulfide, acetate (salt) (1:x); DOTA-(Tyr3,Thr8)-Octreotide acetate; DOTA-[Tyr3] Octreotide Acid (Octreotate) acetate; DOTA-octreotate acetate; DOTA-[Tyr3]-Octreotide Acid acetate. CAS No. 177943-89-4. Pack Sizes: 5 mg. Product ID: BAT-010211. Molecular formula: C65H90N14O19S2.xC2H4O2. Mole weight: 1435.63 (free base). Custom synthesis is available. Send your inquiries for more information. | London |
| D-Thr(6)-Octreotide Acetate | D-Thr(6)-0ctreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-D-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-,cyclic (2→7)-disulfide, [R-(R*,R*)]-, acetate (salt) (9CI). CAS No. 87759-90-8. Pack Sizes: 10 mg. Product ID: B1370-449813. Molecular formula: C49H66N10O10S2.xC2H4O2. Custom synthesis is available. Send your inquiries for more information. | London |
| L-Phe(1)-Octreotide trifluoroacetate salt | L-Phe(1)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: H-L-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol trifluoroacetate salt (Disulfide bridge: Cys2-Cys7). Pack Sizes: 10 mg. Product ID: B1370-449818. Custom synthesis is available. Send your inquiries for more information. | London |
| L-Threoninol(Ac)-8-Octreotide | L-Threoninol(Ac)-8-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol-Ac(Cys2&Cys7 bridge); DPhe-CF-DTrp-KTC-Thr-ol-Ac(Cys2&Cys7 bridge); O1.8-Acetyloctreotide; Octreotide EP Impurity F; D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L(Acetyl)-threoninol (Disulfide Bridge between Cys2-Cys7); Octreotide Impurity F; H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Ac-Thr-ol (Disulfide bridge: Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[1-[(acetyloxy)methyl]-2-hydroxypropyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; O-Acetyl Octreotide; [O1(AC)]8-Octreotide; (L-Threoninol(Ac)8)-Octreotide. CAS No. 133304-81-1. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014748. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. Custom synthesis is available. Send your inquiries for more information. | London |
| L-Threoninol(Ac)-8-Octreotide trifluoroacetate salt | Threoninol(Ac)-8-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Ac-Thr-ol trifluoroacetate salt (Disulfide bridge: Cys2-Cys7); O-Acetyl Octreotide trifluoroacetate salt. Pack Sizes: 10 mg. Product ID: B1370-449816. Custom synthesis is available. Send your inquiries for more information. | London |
| Lys(Ac)-Octreotide | Lys(Ac)-Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Uses: Radiopharmaceuticals. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys(Ac)-Thr-Cys-Thr-ol(Cys2&Cys7 bridge); N6.5-Acetyloctreotide; D-Phe-c(Cys-Phe-D-Trp-Lys(Ac)-Thr-Cys)-Thr-ol; Lys(Ac) 5 Octreotide; D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl(acetyl)-L-threonyl-L-cystyl-L-threoninol (Disulfide Bridge between Cys2-Cys7); L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide; D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-L-cysteinamide cyclic (2→7)-disulfide; L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-N6-acetyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, [R-(R*,R*)]-; Octreotide EP Impurity H; Octreotide Impurity H; Acetyl-Lys5-octreotide; D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-(N-acetyl)-L-lysyl-L-threonyl-L-hemicystyl-L-threoninol cyclic (2→7)-disulfide. CAS No. 173606-11-6. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014750. Molecular formula: C51H68N10O11S2. Mole weight: 1061.28. Custom synthes | London |
| Octreotide | Octreotide is an inhibitor of growth hormone, glucagon and insulin. It is also an agonist for sst2, sst3 and sst5 somatostatin receptors, hormone-secreting tumors. Uses: The treatment of hormone-secreting tumors, etc. Group: Pharmaceutical. Alternative Names: SMS 201-995; Phe-Cys-Phe-Trp-Lys-Thr-Cys-Thr (Disulfide bridge: Cys2-Cys7); H-D-Phe-Cys(1)-Phe-D-Trp-Lys-Thr-Cys(1)-Thr-ol; D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol (2->7)-disulfide; Sandostatin; Longastatin; [R-(R*,R*)]-D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[2-hydroxy-1-(hydroxy-methyl)propyl]-cysteinamide cyclic(2->7)-disulfide; Samilstin; SMS 201-995. CAS No. 83150-76-9. Pack Sizes: 5 mg. Product ID: BAT-010572. Molecular formula: C49H66N10O10S2. Mole weight: 1019.24. Custom synthesis is available. Send your inquiries for more information. | London |
| Octreotide Acetate | Octreotide acetate is a long-acting octapeptide with pharmacologic actions similars to the natural hormone somatostatin. It is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. It was approved as an injectable depot formulation used for acromegaly, gigantism, thyrotropinoma, diarrhea and flushing episodes associated with carcinoid syndrome, and diarrhea in patients with vasoactive intestinal peptide-secreting tumors. It is a gastric antisecretory agent andcould inhibit the secretion of insulin and glucagon. It reduces production of IGF-1 and IGF-2 by the liver by modulation of growth-hormone secretion from the pituitary gland. It decreased the urinary excretion of uric acid as well as the plasma concentrations of glucagon and insulin. It decreased the urinary excretion of sodium and chloride without significiant influence on creatinine clearance, while the concentrations of lactic acid, pyruvic acid in blood, and cyclic AMP in plasma were not changed. It was first synthesized in 1979 by the chemist Wilfried Bauer and was developed by Novartis Pharmaceuticals. Uses: Antineoplastic agents, hormonal. Group: Pharmaceutical. Alternative Names: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, acetate (1:x); H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol.xCH3CO2H (Disulfide B | London |
| Pasireotide acetate | Pasireotide acetate is a cyclic peptide, which can improve agonist activity at somatostatin receptors. Group: Pharmaceutical. Alternative Names: Pasireotide acetate salt; SOM230 acetate. CAS No. 396091-76-2. Pack Sizes: 5 mg. Product ID: BAT-016459. Molecular formula: C60H70N10O11. Mole weight: 1107.26. Custom synthesis is available. Send your inquiries for more information. | London |
| RC 160 | RC 160 is a cyclic octapeptide somatostatin analog (Ki= 0.7, 5.4, 30.9, 45 and > 1000 nM for sst5, sst2, sst3, sst4 and sst1 receptors respectively). RC 160 is a peptide neurokinin-1 receptor (NK1) antagonist and inhibits increases in vascular permeability stimulated by substance P in a concentration-dependent manner in isolated guinea pig trachea and main bronchi. It is used in the treatment of esophageal variceal bleeding in patients with cirrhotic liver disease and AIDS-related diarrhea. Uses: Antineoplastic agents. Group: Pharmaceutical. Alternative Names: D-Phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide, cyclic (2→7)-disulfide; BMY-41606; BMY 41606; BMY41606; RC160; RC-160; DP-05-094; Octastatin; L-Tryptophanamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide; RC 160 (protein); Vapreotide; D-Phe-Cys-Trp-D-Trp-Lys-Val-Cys-Trp-CONH2 (Disulfide bridge: Cys2-Cys7). CAS No. 103222-11-3. Pack Sizes: 5 mg. Product ID: BAT-006135. Molecular formula: C57H70N12O9S2. Mole weight: 1131.37. Custom synthesis is available. Send your inquiries for more information. | London |
| Telotristat Etiprate | Telotristat Etiprate (LX 1606 Hippurate) is an orally bioavailable, tryptophan hydroxylase (TPH) inhibitor with potential antiserotonergic activity. Uses: Combination therapy of somatostatin analogue (ssa) and telotristat ethyl. Group: Pharmaceutical. Alternative Names: LX 1606 Hippurate; LX1606 Hippurate; LX-1606 Hippurate; Telotristat ethyl hippurate; (S)-ethyl 2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate 2-benzamidoacetate. CAS No. 1137608-69-5. Pack Sizes: 10 mg. Product ID: B0084-286447. Molecular formula: C36H35ClF3N7O6. Mole weight: 754.15. Custom synthesis is available. Send your inquiries for more information. | London |
| Trisulfide Octreotide | Trisulfide Octreotide is an impurity of Octreotide, which is a synthetic long-acting cyclic octapeptide used as a more potent inhibitor of growth hormone, glucagon, and insulin than somatostatin. Group: Pharmaceutical. Alternative Names: DPhe-Cys-Phe-DTrp-Lys-Thr-Cys-Thr-ol(Cys2&Cys7 Trisulfide bridge); Octreotide EP Impurity E; D-Phenylalanyl-S-sulfanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2→7)-trisulfide; D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-Thr-ol (Trisulfide Bridge between Cys2-Cys7); D-Phenylalanyl-L-cystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cystyl-L-threoninol (Trisulfide Bridge between Cys2-Cys7); Octreotide impurity E; DPhe-CF-DTrp-KTC-Thr-ol(Cys2&Cys7 Trisulfide bridge). CAS No. 1546983-27-0. Pack Sizes: 1mg;1g;10g. Product ID: BAT-014621. Molecular formula: C49H66N10O10S3. Mole weight: 1051.31. Custom synthesis is available. Send your inquiries for more information. | London |
| TT-232 | TT 232 is a somatostatin analog that acts as a peptide agonist for sst1/sst4 somatostatin receptors. TT 232 inhibits tyrosine kinase activity in human colon tumor cell lines. TT 232 was shown to suppress proliferation and induce apoptosis in a pancreatic tumor cell line. Group: Pharmaceutical. Alternative Names: TT2-32; TT2 32; TT232; TT-232; TT 232; CAP 232; CAP-232; CAP232. CAS No. 147159-51-1. Pack Sizes: 20 mg. Product ID: BAT-010841. Molecular formula: C45H58N10O9S2. Mole weight: 947.13. Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
